Wockhardt to market generic Cefotaxime sodium injection in United States

By Lisa Kerner

Charlotte, N.C., Aug. 31 - Wockhardt Ltd received approval from the Food and Drug Administration to market Cefotaxime sodium (1 gm) injection in the United States.

The Mumbai, India-based company's U.S. subsidiary, Wockhardt USA Inc., will launch this cephalosporin antibiotic, the generic version of Sanofi-Aventis Claforan injection, in the next few weeks, according to a news release.

This is the pharmaceutical company's second approval for sterile cephalosporins and its sixth approval in the last eight months.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.